TY - JOUR
T1 - Reliability of a generative artificial intelligence tool for pediatric familial Mediterranean fever: insights from a multicentre expert survey
AU - La Bella, Saverio
AU - Attanasi, Marina
AU - Porreca, Annamaria
AU - Di Ludovico, Armando
AU - Maggio, Maria Cristina
AU - Gallizzi, Romina
AU - La Torre, Francesco
AU - Rigante, Donato
AU - Soscia, Francesca
AU - Ardenti Morini, Francesca
AU - Insalaco, Antonella
AU - Natale, Marco Francesco
AU - Chiarelli, Francesco
AU - Simonini, Gabriele
AU - De Benedetti, Fabrizio
AU - Gattorno, Marco
AU - Breda, Luciana
PY - 2024
Y1 - 2024
N2 - Background: Artificial intelligence (AI) has become a popular tool for clinical and research use in the medical field. The aim of this study was to evaluate the accuracy and reliability of a generative AI tool on pediatric familial Mediterranean fever (FMF).
Methods: Fifteen questions repeated thrice on pediatric FMF were prompted to the popular generative AI tool Microsoft Copilot with Chat-GPT 4.0. Nine pediatric rheumatology experts rated response accuracy with a blinded mechanism using a Likert-like scale with values from 1 to 5.
Results: Median values for overall responses at the initial assessment ranged from 2.00 to 5.00. During the second assessment, median values spanned from 2.00 to 4.00, while for the third assessment, they ranged from 3.00 to 4.00. Intra-rater variability showed poor to moderate agreement (intraclass correlation coefficient range: -0.151 to 0.534). A diminishing level of agreement among experts over time was documented, as highlighted by Krippendorff's alpha coefficient values, ranging from 0.136 (at the first response) to 0.132 (at the second response) to 0.089 (at the third response). Lastly, experts displayed varying levels of trust in AI pre- and post-survey.
Conclusions: AI has promising implications in pediatric rheumatology, including early diagnosis and management optimization, but challenges persist due to uncertain information reliability and the lack of expert validation. Our survey revealed considerable inaccuracies and incompleteness in AI-generated responses regarding FMF, with poor intra- and extra-rater reliability. Human validation remains crucial in managing AI-generated medical information.
AB - Background: Artificial intelligence (AI) has become a popular tool for clinical and research use in the medical field. The aim of this study was to evaluate the accuracy and reliability of a generative AI tool on pediatric familial Mediterranean fever (FMF).
Methods: Fifteen questions repeated thrice on pediatric FMF were prompted to the popular generative AI tool Microsoft Copilot with Chat-GPT 4.0. Nine pediatric rheumatology experts rated response accuracy with a blinded mechanism using a Likert-like scale with values from 1 to 5.
Results: Median values for overall responses at the initial assessment ranged from 2.00 to 5.00. During the second assessment, median values spanned from 2.00 to 4.00, while for the third assessment, they ranged from 3.00 to 4.00. Intra-rater variability showed poor to moderate agreement (intraclass correlation coefficient range: -0.151 to 0.534). A diminishing level of agreement among experts over time was documented, as highlighted by Krippendorff's alpha coefficient values, ranging from 0.136 (at the first response) to 0.132 (at the second response) to 0.089 (at the third response). Lastly, experts displayed varying levels of trust in AI pre- and post-survey.
Conclusions: AI has promising implications in pediatric rheumatology, including early diagnosis and management optimization, but challenges persist due to uncertain information reliability and the lack of expert validation. Our survey revealed considerable inaccuracies and incompleteness in AI-generated responses regarding FMF, with poor intra- and extra-rater reliability. Human validation remains crucial in managing AI-generated medical information.
KW - Artificial intelligence
KW - Familial Mediterranean fever
KW - Artificial intelligence
KW - Familial Mediterranean fever
UR - http://hdl.handle.net/10807/288382
U2 - 10.1186/s12969-024-01011-0
DO - 10.1186/s12969-024-01011-0
M3 - Article
SN - 1546-0096
VL - 22
SP - 1
EP - 11
JO - PEDIATRIC RHEUMATOLOGY ONLINE JOURNAL
JF - PEDIATRIC RHEUMATOLOGY ONLINE JOURNAL
ER -